Insulin-degrading enzyme and Alzheimer disease: A genetic association study in the Han Chinese

Neurology

Volumn 63, Issue 2, 2004, Pages 241-245

  Bian, L ^a   Yang, J D ^a   Guo, T W ^a   Sun, Y ^a   Duan, S W ^a   Chen, W Y ^a   Pan, Y X ^a   Feng, G Y ^b   He, L ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b SHANGHAI MENTAL HEALTH CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E4; DNA; GAMMA SECRETASE; INSULIN;

5' UNTRANSLATED REGION; AGED; ALZHEIMER DISEASE; ARTICLE; CHINESE; CONTROLLED STUDY; DEGENERATIVE DISEASE; EXON; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; POLYMERASE CHAIN REACTION; POPULATION GENETICS; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 3242777669     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000129987.70037.DB     Document Type: Article

References (26)

1. Ashall F, Goate AM. Role of the β-amyloid precursor protein in Alzheimer's disease. Trends Biochem Sci 1994;19:42-46.
2. Hardy J. Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci 1997;20:154-159.
3. Hardy J. Molecular genetics of Alzheimer's disease. Acta Neurol Scand (Suppl) 1996;165:13-17.
4. Saunders AM, Strittmatter WJ, Schmechel D, et al. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993;43:1467-1472.
5. Myers A, Holmans P, Marshall H, et al. Susceptibility locus for Alzheimer's disease on chromosome 10. Science 2000;290:2304-2305.
6. Ertekin-Taner N, Graff-Radford N, Younkin LH, et al. Linkage of plasma Aβ42 to a quantitative locus on chromosome 10 in late-onset Alzheimer's disease pedigrees. Science 2000;290:2303-2304.
7. Bertram L, Blacker D, Mullin K, et al. Evidence for genetic linkage of Alzheimer's disease to chromosome 10q. Science 2000;290:2302-2303.
8. Li YJ, Scott WK, Hedges DJ, et al. Age at onset in two common neuro-degenerative disease is genetically controlled. Am J Hum Genet 2002;70:985-993.
9. Qiu WQ, Walsh DM, Ye Z, et al. Iusulin-degrading enzyme regulates extracellular levels of amyloid β-protein by degradation. J Biol Chem 1998;273:32730-32738.
10. Vekrellis K, Ye Z, Qiu WQ, et al. Neurons regulate extracellular levels of amyloid beta-protein via proteolysis by insulin-degrading enzyme. J Neurosci 2000;20:1657-1665.
11. Edbauer D, Willem M, Lammich S, Steiner H, Haass C. Insulin-degrading enzyme rapidly removes the β-amyloid precursor protein intracellular domain (AICD). J Biol Chem 2002;277:13389-13393.
12. Farris W, Mansourian S, Chang Y, et al. Insulin-degrading enzyme regulates the levels of insulin, amyloid β-protein, and the β-amyloid precursor protein intracellular domain in vivo. Proc Natl Acad Sci USA 2003;100:4162-4167.
13. Miller BC, Eckman EA, Sambamurti K, et al. Amyloid-beta peptide levels in brain are inversely correlated with insulysin activity levels in vivo. Proc Natl Acad Sci USA 2003;100:6221-6226.
14. Ait-Ghezala G, Abdullah L, Crescentini R, et al. Confirmation of association between D10S583 and Alzheimer's disease in a case-control sample. Neurosci Lett 2002;325:87-90.
15. Abraham R, Myers A, Wavrant F, et al. Substantial linkage disequilibrium across the insulin-degrading enzyme locus but no association with late-onset Alzheimer's disease. Hum Genet 2001;109:646-652.
16. Boussaha M, Hannequin D, Verpillat P, Brice A, Frebourg T, Campion D. Polymorphisms of insulin degrading enzyme gene are not associated with Alzheimer's disease. Neurosci Lett 2002;329:121-123.
17. Edland SD, Wavrant-De Vriesé F, Compton D, et al. Insulin degrading enzyme (IDE) genetic variants and risk of Alzheimer's disease: evidence of effect modification by apolipoprotein E (APOE). Neurosci Lett 2003;345:21-24.
18. Cook DG, Leverenz JB, McMillan PJ, et al. Reduced hippocampal insulin-degrading enzyme in late-onset Alzheimer's disease is associated with the apolipoprotein e ε4 allele. Am J Pathol 2003;162:313-319.
19. Craft S, Asthana S, Schellenberg G, et al. Insulin-degrading enzyme in late-onset Alzheimer's disease differs according to apolipoprotein E genotype and gender. Neuroendocrinology 1999;70:146-152.
20. Mckhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
21. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association, 1994.
22. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 1990;31:545-548.
23. Zhao JH, Curtis D, Sham PC. Model-free analysis and permutation tests for allelic associations. Hum Hered 2000;50:133-139.
24. Sham PC, Curtis D. Monte Carlo tests for associations between disease and alleles at highly polymorphic loci. Ann Hum Genet 1995;59:97-105.
25. Lewontin RC. On measures of gametic disequilibrium. Genetics 1988;120:849-852.
26. Groves CJ, Wiltshire S, Smedley D, et al. Association and haplotype analysis of the insulin-degrading enzyme (IDE) gene, a strong positional and biological candidate for type 2 diabetes susceptibility. Diabetes 2003;52:1300-1305.